Alpha 1 Antitrypsin Deficiency molecular mechanisms in liver organoids

G. GOMEZ MARIANO (Madrid, Spain), N. Matamala (Madrid, Spain), S. Martínez (Madrid, Spain), I. Justo (Madrid, Spain), A. Marcacuzco (Madrid, Spain), C. Jiménez (Madrid, Spain), M. Huch (Cambridge, United Kingdom), B. Martínez-Delgado (Madrid, Spain)

Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session: New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session type: Thematic Poster
Number: 4061
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. GOMEZ MARIANO (Madrid, Spain), N. Matamala (Madrid, Spain), S. Martínez (Madrid, Spain), I. Justo (Madrid, Spain), A. Marcacuzco (Madrid, Spain), C. Jiménez (Madrid, Spain), M. Huch (Cambridge, United Kingdom), B. Martínez-Delgado (Madrid, Spain). Alpha 1 Antitrypsin Deficiency molecular mechanisms in liver organoids. 4061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014



Cellular and molecular mechanisms of endothelial dysfunction of ACOS-syndrome
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Deriving type II alveolar cells from pluripotent stem cells to produce a novel model of alpha-1 antitrypsin deficiency pathogenesis
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003

LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

Oxidative stress in serum of patients with alpha-1 antitrypsin deficiency
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013


LATE-BREAKING ABSTRACT: Protein tyrosine phosphatase (PTP)alpha promotes profibrotic responses in fibroblasts via Smad signaling
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014


Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


Gene expression network in PiZZ Alpha1 Antitrypsin Deficiency and its relationship with the severity of lung disease
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

Deficiency of immunoproteasome subunit LMP2 increases alternative polarization of alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

Development of a myeloid cell-binding adenovirus for the potential gene therapy of alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

GRP78 is a novel receptor initiating endothelial barrier protective response to oxidized phospholipids
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014


COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021


Molecular mechanisms of pirfenidone activity in human lung fibroblasts
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014


Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012

F alpha-1 antitrypsin polymerization activates endoplasmic reticulum overload response
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014

Telomere attrition in peripheral blood mononuclear cells of children with alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

Alpha 1-antitrypsin deficiency
Source: Breathe 2008; 4: 377-380
Year: 2008